Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fulminant hepatic failure.

Jelica Kurtovic1, Stephen M Riordan, Roger Williams

  • 1Institute of Hepatology, Royal Free and University College Medical School, 69-75 Chenies Mews, London, WC1E 6HX, England.

Current Treatment Options in Gastroenterology
|November 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Csep1P protein from Campylobacter concisus induces a chemokine-dominant inflammatory state in macrophages and enhances proinflammatory response to gut bacteria.

PLoS pathogens·2026
Same author

Multi-Cohort Exploration of Repetitive Element Transcription and DNA Methylation in Human Steatotic Liver Disease.

International journal of molecular sciences·2025
Same author

Age-Dependent Variations in the Distribution of <i>Aeromonas</i> Species in Human Enteric Infections.

Pathogens (Basel, Switzerland)·2025
Same author

Human macrophage response to the emerging enteric pathogen <i>Aeromonas veronii</i>: Inflammation, apoptosis, and downregulation of histones.

Virulence·2024
Same author

Epidural steroid injection technique.

Techniques in vascular and interventional radiology·2024
Same author

Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance.

Journal of hepatology·2024
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Fulminant hepatic failure is a severe condition with high mortality. Liver transplantation is crucial, but limited donor organs necessitate exploring living donors and temporary liver support to improve patient survival.

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Critical Care Medicine

Background:

  • Fulminant hepatic failure (FHF) is a rare, life-threatening condition characterized by severe liver dysfunction, encephalopathy, and multi-organ failure.
  • Despite medical advancements, FHF carries a high mortality rate, with orthotopic liver transplantation (OLT) being the primary curative treatment.
  • Limited availability of cadaveric donor organs and rapid disease progression often preclude timely transplantation.

Purpose of the Study:

  • To review the challenges and emerging strategies in managing fulminant hepatic failure.
  • To highlight the critical role of liver transplantation and explore alternative approaches for patient survival.

Main Methods:

  • Review of current medical literature on fulminant hepatic failure and liver transplantation.

Related Experiment Videos

  • Analysis of the limitations of cadaveric donor organ availability.
  • Discussion of alternative therapeutic strategies including living donor transplantation and temporary liver support.

    • Main Results:

    • Orthotopic liver transplantation significantly improves survival rates in eligible patients with FHF.
    • Living donor liver transplantation offers a viable alternative to address organ shortages.
    • Temporary liver support strategies (auxiliary partial transplantation, hepatocyte transplantation, extracorporeal perfusion) can bridge patients to definitive treatment or native liver regeneration.

    Conclusions:

    • Urgent liver transplantation remains the cornerstone of FHF management.
    • Living donor transplantation and innovative temporary liver support systems are essential to overcome organ scarcity and improve outcomes in FHF.
    • Further research into liver regeneration and advanced support technologies is crucial for enhancing spontaneous survival in FHF patients.